FDA Inspection 1109230 — Abilene Nuclear LLC dba National Central Pharmacy
The FDA completed an inspection of Abilene Nuclear LLC dba National Central Pharmacy on November 7, 2019 in Abilene, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 7, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Abilene, TX (United States)